What is the recommended workup for a patient with suspected color blindness?

Work-up of Color Blindness

Color-vision deficiency testing is performed using pseudoisochromatic plates (such as Ishihara plates) as the primary screening tool, with children who cannot identify numbers using simple object identification instead. 1

Primary Screening Approach

• Pseudoisochromatic plates are the standard first-line test for detecting color vision deficiency in clinical practice 1
• For young children unable to identify numbers, modified plates with simple objects should be used instead 1
• Testing is not routinely performed in asymptomatic individuals but is indicated when:
  • The patient reports symptoms of color discrimination difficulty 1
  • There is a positive family history of color deficiency 1
  • Occupational or educational concerns arise 1

Epidemiology to Guide Testing Decisions

• 8% of males and less than 1% of females have congenital color vision deficiency 1
• The condition is X-linked, making family history particularly relevant in males 1

Confirmatory and Classification Testing

When screening is positive or more detailed assessment is needed:

• The anomaloscope is the gold standard for definitive diagnosis and classification of color vision deficiency type (protan, deutan, tritan) 2
• Farnsworth-Munsell tests (including the D-15 and 100 Hue variants) provide grading of severity and are widely used in clinical practice 2
• Computer-based tests (Cone Contrast Test, Colour Assessment and Diagnosis test, Waggoner Computerized Color Vision Test) offer standardized, reproducible results and are increasingly replacing older lantern tests 3
• Using at least 2 different tests is advisable to ensure diagnostic accuracy, as results between tests can vary and interpretation requires experience 2

Distinguishing Congenital from Acquired Color Vision Deficiency

Key Clinical Distinctions:

• Congenital deficiency affects specific hue discrimination (red-green or blue-yellow) symmetrically in both eyes from birth 2, 4
• Acquired deficiency may be asymmetric, progressive, and associated with other visual symptoms or systemic disease 4

When to Suspect Acquired Color Vision Deficiency:

• Unilateral or asymmetric color perception problems suggest ocular or neurologic pathology 4
• Recent onset in a previously normal individual 4
• Associated visual symptoms such as decreased acuity, visual field defects, or other neurologic signs 4
• Tritan (blue-yellow) defects are more common in acquired disease affecting the S-cone pathway 4

Comprehensive Ophthalmologic Evaluation for Acquired Cases

When acquired color vision deficiency is suspected, a full ophthalmologic work-up is mandatory 5:

• Measure distance and near visual acuity to establish baseline functional vision 5
• Perform pupillary examination to detect afferent defects indicating optic nerve dysfunction 5
• Conduct slit-lamp biomicroscopy to evaluate corneal clarity, anterior chamber, lens, and vitreous 5
• Measure intraocular pressure to screen for glaucoma 5
• Perform dilated fundus examination with indirect ophthalmoscopy to assess retina, optic nerve, and macular integrity 5
• Optical coherence tomography (OCT) of the macula and optic nerve to identify structural pathology 5
• Automated visual field testing to detect scotomas or peripheral defects 5

Neurologic and Systemic Evaluation

For acquired color vision deficiency, particularly with posterior circulation involvement:

• Brain imaging (MRI preferred) is essential when cerebral achromatopsia is suspected, as 22% of posterior cerebral artery stroke patients show significant color discrimination problems 6
• Left hemisphere and bilateral lesions are more strongly associated with color perception deficits than right hemisphere lesions alone 6
• Ventral occipital-temporal regions are the critical anatomic areas to evaluate 6

Practical Management Considerations

• Early identification in children allows educators to be informed that the child may have difficulty with color-dependent learning materials 1
• Occupational counseling may be needed, as color vision deficiency can affect career choices in medicine and other fields 7
• No treatment exists for congenital color vision deficiency; management focuses on adaptation and accommodation 1
• Acquired deficiency requires treatment of the underlying ocular, neurologic, or systemic disease 4

Common Pitfalls to Avoid

• Do not assume normal color vision based on patient report alone—many individuals with congenital deficiency are unaware of their condition until formally tested 1
• Do not use a single test in isolation when precise classification or occupational clearance is required 2
• Do not dismiss unilateral or recent-onset color vision complaints as benign—these warrant comprehensive ophthalmologic and potentially neurologic evaluation 4, 6
• Ensure adequate lighting and test conditions, as external factors significantly influence test performance 2